GLP-1 pill can reduce heavy drinking in adults who have a problem with alcohol, study finds
A new study suggests that oral semaglutide, a GLP-1 medication, may help reduce heavy drinking in adults with alcohol use disorder. Researchers believe this could offer a new treatment option for those who have not responded to existing therapies.
Why it matters
Alcohol use disorder affects millions, and the potential repurposing of weight-loss drugs could significantly impact public health treatment strategies.
The Independent and Yahoo may earn commission from links in this article. Pricing and availability are subject to change.
GLP-1 pill can reduce heavy drinking in adults who have a problem with alcohol, study finds Taking popular semaglutide weight-loss pills are effective at reducing heavy drinking in people with chronic alcohol use disorder , a new study has found.
Roughly 27 million American adults currently suffer from the condition, which leaves people at an increased risk of liver disease , cancer and premature death. Treating the disorder, also known as AUD or alcoholism, can be difficult to manage and no new medications have been approved for AUD in nearly two decades.
These pills could help provide a new avenue for treatment, the study's authors said.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in